On August 19, Insulet rose 5.06% in regular trading, trading at $146.78 USD/share, with Turnover of $96.51 million.

Within the Health Care Equipment sector where Insulet belongs, among individual stocks, Stryker up 1.22%, Profusa Inc up 164.46%, Intuitive Surgical up 1.73%, Boston Scientific down 0.46%, Abbott Laboratories up 2.25%.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers the Omnipod System, a self-adhesive disposable tubeless device worn on the body for up to three days at a time, along with its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)